Fosfluconazole
| This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2006) |
| Systematic (IUPAC) name | |
|---|---|
| {[2-(2,4-difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-yl]oxy}phosphonic acid | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ℞ Prescription only |
| Routes | IV |
| Identifiers | |
| ATC code | None |
| PubChem | CID 214356 |
| ChemSpider | 185843 |
| UNII | 3JIJ299EWH |
| Chemical data | |
| Formula | C13H13F2N6O4P |
| Mol. mass | 386.25 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Fosfluconazole (INN) is a water-soluble phosphate prodrug of fluconazole - a triazole antifungal drug used in the treatment and prevention of superficial and systemic fungal infections. The phosphate ester bond is hydrolysed by the action of a phosphatase - an enzyme that removes a phosphate group from its substrate by hydrolysing phosphoric acid monoesters into a phosphate ion and a molecule with a free hydroxyl group (see dephosphorylation).
|
||||||||||||||||||||||||||||||||||||||||||
| This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |